Skip to content

Trending News

What Just Happened
5 years agoOptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients – Stockhouse 5 years agoOM1 Launches Multiple Sclerosis Registry with More than 20000 Patients Prospectively Followed with Deep Clinical Data – Markets Insider 5 years agoReal-World Evidence And Its Use In Advertising Of Medicinal Products In The EU And US – Media, Telecoms, IT, Entertainment – Worldwide – Mondaq News Alerts 5 years agoNational Evaluation System for health Technology Coordinating Center Adds Clinical Laboratory and Patient Engagement Expertise to Governing Committee – Business Wire 5 years agoAbnormal temperatures linked to climate change cause over 740,000 deaths annually in India
Saturday, Mar 7, 2026
Primary Menu
  • Categories
    • Real World Research (RWR)
    • RWD Sources
    • Movers and Shakers
    • RWE – Real World Evidence
    • Health Tech
    • Medical Devices
    • RWR & COVID 19
    • Regulatory
    • Oncology
    • Mental Health
    • Schrödinger’s Donkey
    • Decentralised Trials
    • Recently Released
  • Editorials
  • RWR
  • Newsfeed
  • FAQ
  • ABOUT
    • About RWR News
    • About the Authors
    • RWR News Editorial Policy
  • RESOURCES
    • Phoenix RWR Consulting
    • RedBird Reg Intel Tools
    • RWR Study Master File

Tag: Drugs

  • Home
  • Drugs
Category:
  • Real World Research (RWR)
  • Recently Released
  • RWE - Real World Evidence

Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma – Medical Bag

Real-World Research shows comparative risk for mAbs used in severe asthma patients CONTEXT:  According to the findings of a real-world research study published in Clinical and Translational Allergy, patients receiving Continue Reading

Posted On : July 3, 2021 Published By : Mark Lorkowski
Category:
  • Recently Released
  • RWE - Real World Evidence

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar – FiercePharma

IMPACT: Taking insulin and a GLP-1 agonist significantly increases the ability of achievement stable blood sugar levels READ TIME: 2 mins * 1. “Sanofi’s Soliqua combines an insulin with a Continue Reading

Posted On : February 8, 2021 Published By : Mark Lorkowski
Category:
  • Recently Released
  • RWE - Real World Evidence

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program – MD Linx

EXPERT NOTES: CONTEXT:  Peer Reviewed Data, RWE of Effectiveness of Cabozantinib IMPACT:  In the largest real-world study to date, cabozantinib was effective in unselected, heavily pretreated patients with mRCC. Initiation Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully
Category:
  • Pharmacovigilance (post-approval)
  • Recently Released

News: Human medicines: highlights of 2020

Quick Notes: *Within the report the “conditional marketing authorisations” and “monitoring in real-life” are the “go to” section to see what the post-authorisation obligations were and what the EMA is Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully

XKCD Mental Break

Coffee Break Cartoon XKCD

We don’t spam! Read more in our privacy policy

Check your inbox or spam folder to confirm your signup and download

Copyright RedBird 2021
Theme: Royal Magazine by ThemeinWP
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Impressum
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (US)
  • Cookie Policy (CA)
  • Privacy Statement (CA)
  • Disclaimer
  • Privacy Statement (US)